These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 20307764)

  • 1. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants.
    Lazarovici TS; Yahalom R; Taicher S; Schwartz-Arad D; Peleg O; Yarom N
    J Oral Maxillofac Surg; 2010 Apr; 68(4):790-6. PubMed ID: 20307764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bisphosphonates and dental implants.
    McLeod NM
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1355. PubMed ID: 19446233
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
    Lazarovici TS; Yahalom R; Taicher S; Elad S; Hardan I; Yarom N
    J Oral Maxillofac Surg; 2009 Apr; 67(4):850-5. PubMed ID: 19304045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.
    Goss A; Bartold M; Sambrook P; Hawker P
    J Oral Maxillofac Surg; 2010 Feb; 68(2):337-43. PubMed ID: 20116705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
    Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws.
    Holzinger D; Seemann R; Matoni N; Ewers R; Millesi W; Wutzl A
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1937.e1-8. PubMed ID: 25234534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.
    Epstein MS; Wicknick FW; Epstein JB; Berenson JR; Gorsky M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov; 110(5):593-6. PubMed ID: 20955948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
    Urade M; Tanaka N; Furusawa K; Shimada J; Shibata T; Kirita T; Yamamoto T; Ikebe T; Kitagawa Y; Fukuta J
    J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT; Chiang WF; Chuang CY; Chang SW
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for bisphosphonate-related osteonecrosis of the jaws.
    Fleisher KE; Glickman RS
    J Oral Maxillofac Surg; 2011 Apr; 69(4):959; author reply 959-60. PubMed ID: 21440820
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Indiana Dent Assoc; 2007-2008 Winter; 86(4):4-8. PubMed ID: 18363257
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteonecrosis of the jaw.
    Reilly MM; Moore S
    Oncology (Williston Park); 2008 Feb; 22(2 Suppl Nurse Ed):39-41. PubMed ID: 18431898
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.
    Naik NH; Russo TA
    Clin Infect Dis; 2009 Dec; 49(11):1729-32. PubMed ID: 19886792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.
    Bedogni A; Bettini G; Totola A; Saia G; Nocini PF
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1662-6. PubMed ID: 20561470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes mellitus and bisphosphonate-related osteonecrosis of the jaws].
    Urade M
    Clin Calcium; 2009 Sep; 19(9):1332-8. PubMed ID: 19721206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.